10 Multiple Sclerosis Clinical Trials in Cleveland, MS (2026)

Q: How do I join a clinical trial in Cleveland?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Cleveland research site will contact you.

Recruiting Multiple Sclerosis Studies in Cleveland

NCT07406282Recruiting

A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

Prostate cancer is the most common non-skin cancer among men in the United States. For some men, the cancer has already spread to other parts of the body at the time of diagnosis; this is called metas...

Cleveland, MS1,400 participantsBayer

View Study Details

NCT07011914Recruiting

Care in Multiple Sclerosis (MS)

This study is structured around three main aims. In Aim 1, investigators will conduct community-based participatory research (CBPR) to develop culturally tailored methods to assess childhood adversit...

Cleveland, MS300 participantsNYU Langone Health

View Study Details

NCT06034002Recruiting

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

This study is being conducted to evaluate the safety, tolerability, dose-limiting toxicity (DLT) and determine the maximum tolerated dose (MTD) and/or recommended dose(s) for expansion (RDE) of INCA03...

Cleveland, MS290 participantsIncyte Corporation

View Study Details

NCT07082920Recruiting

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

The purpose of this study is to identify the recommended phase 2 combination dose (RP2CD) of JNJ-78278343 in combination with JNJ-95298177 in Part 1 (Dose confirmation) of the study and to determine h...

Cleveland, MS140 participantsJanssen Research & Development, LLC

View Study Details

NCT06529406Recruiting

Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod

A multi-center pilot study to evaluate safety and efficacy of ozanimod as de-escalation therapy in clinically stable MS patients previously treated with anti-CD20 therapy....

Cleveland, MS100 participantsUniversity of Colorado, Denver

View Study Details

NCT07187180Recruiting

Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate

Many consider laser enucleation of the prostate the new 'gold standard' for the surgical treatment of benign prostatic hyperplasia (BPH) due to its excellent outcomes, high success rates, and long-ter...

Cleveland, MS50 participantsSmita De

View Study Details

NCT07424027Recruiting

Central Vein Sign in Multiple Sclerosis Extension Study

Multiple sclerosis (MS) is a common disease of the central nervous system that affects almost 1 million people in the United States. However, diagnosing MS can be difficult and often leads to misdiagn...

Cleveland, MS40 participantsThe Cleveland Clinic

View Study Details

NCT07319871Recruiting

A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

The purpose of this study is to identify the recommended phase 2 combination dose (RP2CD) of Pasritamig in combination with JNJ-86974680 in Part 1 (Dose finding) of the study and to determine how safe...

Cleveland, MS40 participantsJanssen Research & Development, LLC

View Study Details

NCT07224373Recruiting

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with Multip...

Cleveland, MS24 participantsAstraZeneca

View Study Details

NCT05964829Recruiting

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

The purpose of this research is to support the clinical value of the Cionic Neural Sleeve for individuals diagnosed with multiple sclerosis (MS)....

Cleveland, MS14 participantsCionic, Inc.

View Study Details

About Multiple Sclerosis Clinical Trials in Cleveland

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 10 multiple sclerosis clinical trials recruiting participants in Cleveland, MS. These studies are seeking a combined 2,398 participants. Research is being sponsored by Bayer, NYU Langone Health, Incyte Corporation and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Cleveland — FAQ

Are there multiple sclerosis clinical trials in Cleveland?

Yes, there are 10 multiple sclerosis clinical trials currently recruiting in Cleveland, MS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cleveland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cleveland research site will contact you about next steps.

Are clinical trials in Cleveland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cleveland studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 10 active trials in Cleveland are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 13, 2026 from ClinicalTrials.gov